NITRIC-OXIDE SYNTHASE INHIBITOR ALTERS PAPILLARY-MUSCLE FORCE-FREQUENCY-RELATIONSHIP

被引:0
作者
FINKEL, MS
ODDIS, CV
MAYER, OH
HATTLER, BG
SIMMONS, RL
机构
[1] UNIV PITTSBURGH,SCH MED,DEPT MED,PITTSBURGH,PA
[2] UNIV PITTSBURGH,SCH MED,DEPT PHARMACOL,PITTSBURGH,PA
[3] UNIV PITTSBURGH,SCH MED,DEPT SURG,PITTSBURGH,PA
[4] UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We provide evidence for an immediate effect of N-G-monomethyl-L-arginine (L-NMMA) on the force-frequency relationship in isolated hamster papillary muscles. L-NMMA (competitive inhibitor of nitric oxide synthase) reversed the force-frequency relationship (staircase effect) in isolated hamster papillary muscles from negative to positive (P < .01; ANOVA; n = 6). The addition of L-arginine (substrate for nitric oxide synthase) blocked the L-NMMA effect (P < .01; ANOVA; n = 6). The addition of the nitric oxide (NO) donor, sodium nitroprusside (NTP), significantly increased the level of cGMP in the tissue bath (P < .01; t test; n = 6) and reversed the positive inotropic effect of L-NMMA on staircase (P < .01; ANOVA; n = 6). The addition of 8-Br-cGMP to the bath resulted in a concentration-dependent decrease in tension generated by the papillary muscles (n = 6). Methylene blue (known inhibitor of cGMP) mimicked the effect of L-NMMA on staircase (P < .01; ANOVA; n = 6). L-NMMA also significantly blunted the negative inotropic effect of ryanodine (SR calcium release channel regulator) (P < .01; ANOVA; n = 6). The positive inotropic effect of Bay K 8644 (sarcolemmal, L-type calcium channel regulator) was not affected by L-NMMA (P = NS; ANOVA; n = 6). L-NMMA had no effect on either [H-3]ryanodine or [H-3]PN200-110 (sarcolemmal, L-type calcium channel regulator) binding to cardiac membranes. These findings support a cGMP-dependent role for endogenous NO in myocardial E-C coupling.
引用
收藏
页码:945 / 952
页数:8
相关论文
共 34 条
  • [1] ANDERSON K, 1989, J BIOL CHEM, V264, P1329
  • [2] [Anonymous], 1871, BERICHTE KONIG SACHS, V23, P652
  • [3] CONTROL OF CARDIAC-MUSCLE CELL-FUNCTION BY AN ENDOGENOUS NITRIC-OXIDE SIGNALING SYSTEM
    BALLIGAND, JL
    KELLY, RA
    MARSDEN, PA
    SMITH, TW
    MICHEL, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) : 347 - 351
  • [4] ASSOCIATION BETWEEN SYNTHESIS AND RELEASE OF CGMP AND NITRIC-OXIDE BIOSYNTHESIS BY HEPATOCYTES
    BILLIAR, TR
    CURRAN, RD
    HARBRECHT, BG
    STADLER, J
    WILLIAMS, DL
    OCHOA, JB
    DISILVIO, M
    SIMMONS, RL
    MURRAY, SA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (04): : C1077 - C1082
  • [5] NITRIC-OXIDE ATTENUATES CARDIAC MYOCYTE CONTRACTION
    BRADY, AJB
    WARREN, JB
    POOLEWILSON, PA
    WILLIAMS, TJ
    HARDING, SE
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01): : H176 - H182
  • [6] BRADY AJB, 1992, AM J PHYSIOL, V263, pH1973
  • [7] DEVELOPMENTAL-CHANGES IN CARDIAC MYOCYTE CALCIUM REGULATION
    CHIN, TK
    FRIEDMAN, WF
    KLITZNER, TS
    [J]. CIRCULATION RESEARCH, 1990, 67 (03) : 574 - 579
  • [8] SEQUENCE AND EXPRESSION OF MESSENGER-RNAS ENCODING THE ALPHA-1-SUBUNIT AND ALPHA-2-SUBUNIT OF A DHP-SENSITIVE CALCIUM-CHANNEL
    ELLIS, SB
    WILLIAMS, ME
    WAYS, NR
    BRENNER, R
    SHARP, AH
    LEUNG, AT
    CAMPBELL, KP
    MCKENNA, E
    KOCH, WJ
    HUI, A
    SCHWARTZ, A
    HARPOLD, MM
    [J]. SCIENCE, 1988, 241 (4873) : 1661 - 1664
  • [9] FELDMAN MD, 1988, J APPL CARDIOL, V3, P273
  • [10] INOTROPIC EFFECTS OF CALCIUM-ANTAGONISTS IN THE CARDIOMYOPATHIC SYRIAN-HAMSTER
    FINKEL, MS
    ROMEO, RC
    ODDIS, CV
    SALAMA, G
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 (04) : 546 - 553